[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteoarthritis-oa-of-the-hip\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteoarthritis-oa-of-the-hip":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,49,87,120,148,177,202,224,249],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100641958","post-market-clinical-follow-up-pmcf-study-evaluating-the-safety-and-efficacy-of-tpmed-primary-hip-prosthesis-system-100641958",false,"NCT07651735","Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System","A Multicenter, Prospective, Observational, Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System","Inclusion Criteria:\n\n* Individuals aged 18 years and older,\n* Male or female participants,\n* Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,\n* Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.\n* Subjects who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship).\n* Subjects who have voluntarily signed the written Informed Consent Form (ICF).\n\nExclusion Criteria:\n\n* Subjects currently participating in any other interventional clinical trial.","ALL","18 Years",{"count":19,"type":20},101,"ESTIMATED","OBSERVATIONAL","This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.",[24,25,26,27,28],"Total Hip Arthroplasty (THA)","Hemiarthroplasty","Osteoarthritis (OA) of the Hip","Femoral Neck Fractures","Joint Diseases",[30,31,32,33,34,35],"Hip Prosthesis","Total Hip Prosthesis","Partial Hip Prosthesis","Primary Hip Arthroplasty","Post-Market Clinical Follow-Up (PMCF)","Harris Hip Score (HHS)","RECRUITING","2026-06-10",{"date":39,"type":40},"2026-06-16","ACTUAL",{"date":42,"type":40},"2024-03-12",{"date":44,"type":20},"2029-03-31",{"name":46,"class":47},"TIPMED Medical Device Manufacturing Ltd. Co.","INDUSTRY",4,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":72,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":86},"100610737","platelet-rich-plasma-for-musculoskeletal-conditions-100610737","NCT07231471","Platelet Rich Plasma for Musculoskeletal Conditions","PRP for MSK","Inclusion Criteria:\n\n* 18+ years old\n* Musculoskeletal pathology that may benefit from a PRP injection\n* Failed other conservative treatments\n\nExclusion Criteria:\n\n* No active malignancy\n* No active infection in the area of injection\n* No platelet disorder\n* No active systemic infections\n* No patients currently undergoing dialysis",true,{"count":58,"type":20},10000,"INTERVENTIONAL",[61],"NA","The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.\n\nThis will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.",[64,65,26,66,67,68,69,70,71],"Osteoarthritis (OA)","Osteoarthritis (OA) of the Knee","Osteoarthritis (OA) of the Shoulder","Osteoarthritis Ankle","Elbow Osteoarthritis","Epicondylitis of the Elbow","Plantar Fasciitis of Both Feet","Tendinopathy",[73,74,75,71],"PRP","Platelet Rich Plasma","Osteoarthritis","2026-05-05",{"date":78,"type":40},"2026-05-06",{"date":80,"type":40},"2025-12-29",{"date":82,"type":20},"2035-01-01",{"name":84,"class":85},"University of Utah","OTHER",1,{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":92,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":16,"minAge":94,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":59,"phases":98,"briefSummary":99,"conditions":100,"keywords":105,"overallStatus":110,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":86},"100625073","ketogenic-diet-to-reduce-osteoarthritis-pain-in-mci-100625073","NCT07417891","Ketogenic Diet to Reduce Osteoarthritis Pain in MCI","KDROP-MCI","Inclusion Criteria:\n\n* English speaking\n* Diagnosis of major joint osteoarthritis\n* Diagnosis of mild cognitive impairment\n\nExclusion Criteria:\n\n* Diabetes that requires insulin\n* Cancer requiring chemo- or radiation therapy in the last 2 years\n* Cardiac event within 1 year\n* Recent history of renal stones\n* Diagnosis of fibromyalgia\n* Already following a ketogenic diet\n* Following a dietary pattern that does not allow for a ketogenic approach\n* Unable to control one's diet","55 Years","75 Years",{"count":97,"type":20},10,[61],"Osteoarthritis and mild cognitive impairment are common conditions that share underlying biological processes related to metabolism and inflammation. This study will examine whether a well-formulated ketogenic diet influences pain, physical function, and cognitive outcomes in adults with osteoarthritis and mild cognitive impairment. Participants will follow a supervised ketogenic dietary intervention, with assessments conducted before and after the intervention to evaluate changes in symptoms and related biological markers. The goal of this study is to better understand shared mechanisms between joint pain and cognitive health and to explore whether a ketogenic dietary approach may support symptom management in these populations.",[26,65,66,75,101,102,103,104],"Mild Cognitive Impairment","MCI","Mild Cognitive Impairment (MCI)","Dementia",[106,107,108,109],"ketogenic diet","chronic pain","osteoarthritis","mild cognitive impairment","NOT_YET_RECRUITING","2026-04-30",{"date":113,"type":40},"2026-05-04",{"date":115,"type":20},"2026-06-01",{"date":117,"type":20},"2027-06-01",{"name":119,"class":85},"University of Kansas Medical Center",{"id":121,"slug":122,"hasResults":11,"nctId":123,"briefTitle":124,"officialTitle":125,"acronym":126,"eligibilityCriteria":127,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":128,"enrollmentInfo":129,"targetDuration":131,"studyType":21,"phases":4,"briefSummary":132,"conditions":133,"keywords":134,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":86},"100620628","peng-block--peng-prf-100620628","NCT07360093","PENG Block & PENG PRF","Evaluation of the Clinical Effectiveness of Pericapsular Nerve Group (PENG) Block and Pulsed Radiofrequency Applications in Chronic Hip Pain","PENG-PRF","Inclusion Criteria:\n\n* Presence of chronic hip pain lasting at least 3 months\n* Baseline Visual Analog Scale (VAS) score ≥ 4\n* Clinical and\u002For radiological diagnosis of hip osteoarthritis\n* Inadequate response to conservative treatments\n\nExclusion Criteria:\n\n* Local or systemic infection at the intervention site\n* Coagulopathy or inability to discontinue anticoagulant therapy\n* Hip pain related to malignancy\n* History of previous hip arthroplasty\n* Severe neurological deficit\n* Pregnancy or breastfeeding","80 Years",{"count":130,"type":20},84,"6 Months","The primary aim of this study is to prospectively compare the effects of the pericapsular nerve group (PENG) block alone and the combination of PENG block with pulsed radiofrequency (PRF) on pain intensity in patients with chronic hip pain. As a secondary aim, the effects of both treatment modalities on hip function are intended to be evaluated using valid and reliable functional assessment scales. Through this study, it is aimed to demonstrate the clinical contribution of adding PRF to the PENG block and to identify a more effective and longer-lasting approach for the interventional treatment of chronic hip pain.",[26],[135,136,137,138],"Osteoarthritis, Hip,","Pain, Chronic","Nerve Blockade","Pulsed Radiofrequency Treatment","2026-03-15",{"date":141,"type":40},"2026-03-18",{"date":143,"type":40},"2026-02-01",{"date":145,"type":20},"2027-02-28",{"name":147,"class":85},"Ankara City Hospital Bilkent",{"id":149,"slug":150,"hasResults":11,"nctId":151,"briefTitle":152,"officialTitle":153,"acronym":4,"eligibilityCriteria":154,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":155,"targetDuration":4,"studyType":59,"phases":157,"briefSummary":158,"conditions":159,"keywords":160,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":86},"100617909","the-effectiveness-of-a-herbal-supplement-in-osteoarthritis-100617909","NCT07324746","The Effectiveness of a Herbal Supplement in Osteoarthritis.","Effectiveness of a Herbal Supplement Containing Boswellia Serrata, Curcuma Longa, and Vitis Vinifera in Patients With Osteoarthritis.","Inclusion Criteria:\n\n* Aged ≥ 18\n* Diagnosis of osteoarthritis in knee or hip\n* Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours\n* Lequesne's Functional Index (LFI) score ≥ 7\n* Ambulant patient\n\nExclusion Criteria:\n\n* Pregnant and breastfeeding\n* Autoimmune disease such as rheumatoid arthritis, gout, lupus\n* Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage\n* Expectation of surgery\n* History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months\n* Allergy to one of the intervention's ingredients or NSAIDs\n* Peptic ulceration and upper gastrointestinal haemorrhage\n* High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction\n* Tumor, cancer\n* Abnormal renal or\u002Fand hepatic functions or altered blood chemistry\n* Use of concomitant medication able to interfere with the interventions",{"count":156,"type":20},30,[61],"This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis.\n\nThe primary objective is to determine whether the supplement improves osteoarthritis-related symptoms.\n\nThe supplement will be compared with a placebo.\n\nParticipants will:\n\n* take the supplement and placebo for 4 weeks each, one at a time;\n* complete validated questionnaires (6 times online)\n* perform three performance-based physical tests (6 times online)\n* provide a urine sample",[64,26,65,75],[161,162,163,164,75,165,166,167],"Boswellia serrata","Curcuma longa","Curcumin","Turmeric","Grape extract","Knee osteoarthritis","Hip osteoarthritis","2026-01-27",{"date":170,"type":40},"2026-01-29",{"date":172,"type":40},"2025-12-05",{"date":174,"type":20},"2026-09",{"name":176,"class":85},"Middlesex University",{"id":178,"slug":179,"hasResults":11,"nctId":180,"briefTitle":181,"officialTitle":182,"acronym":4,"eligibilityCriteria":183,"healthyVolunteers":56,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":184,"targetDuration":4,"studyType":59,"phases":186,"briefSummary":187,"conditions":188,"keywords":189,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":193,"lastUpdatePostDateStruct":194,"startDateStruct":196,"completionDateStruct":198,"leadSponsor":200,"locationsCount":86},"100620201","effects-of-different-relaxation-therapies-on-pain-and-sleep-in-hip-and-knee-arthroplasty-patients-100620201","NCT07354542","Effects of Different Relaxation Therapies on Pain and Sleep in Hip and Knee Arthroplasty Patients","Comparison of the Effects of Virtual Reality-based and Traditional Relaxation Therapy on Postoperative Pain and Sleep Quality in Patients Undergoing Hip and Knee Replacement Surgery","Inclusion Criteria:\n\n* Those who volunteered to participate in the research,\n* 18 years and older,\n* No diagnosed mental or sleep problems, epilepsy, or depression,\n* No vision, hearing, or speech problems,\n* Those who speak Turkish,\n* Knee and hip replacement surgery ,\n* No active nausea or vomiting prior to the virtual reality application,\n* According to the Numerical Rating Scale, the patient reports pain.\n* Those receiving analgesia treatment according to clinical protocol,\n* Anyone who owns a mobile phone or tablet capable of playing videos, using any brand of internet provider,\n* Patients who had not previously practiced breathing exercises were included .\n\nExclusion Criteria:\n\n* Having a problem that prevents communication,\n* Being admitted to the ward where the surgery and study were performed at another center,\n\n  . Complications develop after knee and hip replacement surgery,\n* Nausea and vomiting may occur during the procedure.\n* Wanting to withdraw from the research,\n* Experiencing chronic pain.",{"count":185,"type":20},82,[61],"Hip and knee replacement surgery is commonly performed in older adults. After surgery, many patients experience pain, limited movement, and sleep problems. These difficulties can make daily activities such as walking or climbing stairs more challenging and may reduce quality of life during recovery.\n\nRelaxation exercises are often used to help reduce pain and improve sleep after surgery. Virtual reality (VR) is a technology that provides a multisensory experience and may help people relax by shifting their attention away from pain and discomfort.\n\nThis study is designed to compare two different relaxation approaches used after hip and knee replacement surgery. One group of patients will perform relaxation exercises using virtual reality, while another group will perform traditional relaxation exercises. The study will examine pain levels and sleep quality in both groups.\n\nThe results of this study may help to better understand whether virtual reality-based relaxation can be used as an alternative or supportive method for managing pain and sleep problems after joint replacement surgery.",[26,65],[190,191,192],"Postoperative Pain","Sleep Quality","Virtual Reality","2026-01-22",{"date":195,"type":40},"2026-01-23",{"date":197,"type":40},"2024-11-01",{"date":199,"type":20},"2026-01-30",{"name":201,"class":85},"Bartın Unıversity",{"id":203,"slug":204,"hasResults":11,"nctId":205,"briefTitle":206,"officialTitle":207,"acronym":4,"eligibilityCriteria":208,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":209,"targetDuration":4,"studyType":59,"phases":211,"briefSummary":212,"conditions":213,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":214,"lastUpdatePostDateStruct":215,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":221,"locationsCount":223},"100610391","gait-after-tha-direct-anterior-vs-manual-posterior-vs-robotic-posterior-100610391","NCT07226973","Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior","A Prospective, Single-Blinded, Partially Randomized Three-Cohort Study Comparing Manual Direct Anterior and Manual Posterior Approaches to a Non-Randomized Robotic Posterior Cohort for Total Hip Arthroplasty Using Gait Analysis","Inclusion Criteria:\n\n* Adults aged \\>18 undergoing primary elective THA for osteoarthritis\n* BMI \\\u003C35\n* Ability to walk unassisted (cane, walker, wheelchair, ect) for \\> 150 feet preoperatively\n\nExclusion Criteria:\n\n* Previous hip surgery on the affected side\n* Neurological disorders affecting gait\n* Contraindication to either DAA or PA",{"count":210,"type":20},48,[61],"The purpose of this study is to evaluate the gait biomechanics following THA on 3 groups of subjects undergoing DAA (manual) and PA (manual and robotic) surgical approaches.",[26],"2025-11-06",{"date":216,"type":40},"2025-11-12",{"date":218,"type":40},"2025-10-09",{"date":220,"type":20},"2027-11-15",{"name":222,"class":85},"Ochsner Health System",2,{"id":225,"slug":226,"hasResults":11,"nctId":227,"briefTitle":228,"officialTitle":228,"acronym":4,"eligibilityCriteria":229,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":230,"targetDuration":4,"studyType":59,"phases":232,"briefSummary":234,"conditions":235,"keywords":236,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":240,"lastUpdatePostDateStruct":241,"startDateStruct":243,"completionDateStruct":245,"leadSponsor":247,"locationsCount":86},"100562476","phase-4-systemic-oral-glucocorticoids-for-the-treatment-of-acute-osteoarthritis-pain-in-the-emergency-department-100562476","NCT06603662","Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department","Inclusion Criteria:\n\n* Age ≥18 years\n* Acute monoarticular arthritic joint pain affecting native knee, hip, or shoulder presumed to be related to osteoarthritis\n* Acute pain above baseline starting less than 72 hour prior to ED visit\n* Planned discharge from the ED\n* History of osteoarthritis of the affected joint based on radiography performed at index visit or prior available imaging\n\nExclusion Criteria:\n\n* Trauma to the affected joint within 30 days\n* Injection of affected joint within 60 days\n* Prior arthroplasty of the affected joint\n* History of coronary artery disease, severe gastrointestinal bleeding, gastric\u002Fpeptic ulcer disease, chronic kidney disease with GFR less than 30, or platelet disorders (including von Willebrand disease, hemophilia, severe thrombocytopenia with platelets less than 50 k\u002FmcL)\n* Joint pain suspected to be related to rheumatoid arthritis, gout, septic arthritis, or other non-osteoarthritis autoimmune\u002Finflammatory\u002Finfectious arthritis\n* Chronic\u002Fbaseline use of glucocorticoids (greater than 5 mg daily prednisone or equivalent within previous 7 days) or NSAIDs (daily use for more than 2 days prior to presentation)\n* Daily prescription opioid use or active opioid use disorder\n* Illicit drug use\n* Known allergy\u002Fintolerance to ibuprofen\u002FNSAIDs, prednisone, dexamethasone, or other medication precluding ability to participate in one or more study arms\n* Other contraindications to ibuprofen\u002FNSAIDs or glucocorticoids\n* Planned hospitalization from the ED\n* Pregnancy\n* Incarceration\n* Inability to provide informed consent\n* Other conditions that would preclude compliance with the study protocol and medication dosing",{"count":231,"type":20},192,[233],"PHASE4","The purpose of this clinical trial is to compare the analgesic effects (relief of pain) of glucocorticoids (steroids) and pain medication versus pain medication alone in adult patients presenting to the emergency department with joint pain due to osteoarthritis. Steroids are drugs that can reduce inflammation and are used commonly for many different medical conditions.\n\nIn brief, the central aims of the study are to:\n\n1. Assess the efficacy of adding oral glucocorticoid medications to the standard pain medications used to treat the pain of osteoarthritis.\n2. Assess the safety and tolerability of oral glucocorticoid medication for the short-term treatment of osteoarthritis pain.\n\nWe hypothesize that: 1) The addition of glucocorticoids to standard pain medications will improve reported pain scores at 3 days following the initiation of treatment compared to standard pain medications alone and 2) The use of glucocorticoids will be well tolerated.\n\nParticipants in the study will be randomized (like flipping a coin) into one of three groups:\n\n1. Study Group 1 (Control) receiving placebo pills (no active ingredient) once a day for 5 days, plus ibuprofen (pain medication) for 5 days.\n2. Study Group 2 (Intervention A) who will receive prednisone (steroid) once a day for 5 days, plus ibuprofen (pain medication) for 5 days.\n3. Study Group 3 (Intervention B) who will receive one dose of dexamethasone (steroid) followed by placebo pills (no active ingredient) once a day for 4 days, plus ibuprofen (pain medication) for 5 days.\n\nIn all groups, acetaminophen (a different pain medication) can be taken as needed for pain that is not controlled with ibuprofen.\n\nParticipants will:\n\n* Receive follow up phone calls at 1, 3, 7 and 14 days.\n* Report pain scores related to joint pain.\n* Report the number of pills taken of the various medications used in the study.\n* Report any adverse events incurred during the follow up period.",[75,65,66,26],[108,237,238,239],"acute pain","glucocorticosteroids","emergency department","2025-03-26",{"date":242,"type":40},"2025-03-27",{"date":244,"type":40},"2025-02-24",{"date":246,"type":20},"2027-12",{"name":248,"class":85},"WellSpan Health",{"id":250,"slug":251,"hasResults":11,"nctId":252,"briefTitle":253,"officialTitle":253,"acronym":4,"eligibilityCriteria":254,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":255,"enrollmentInfo":256,"targetDuration":4,"studyType":59,"phases":258,"briefSummary":259,"conditions":260,"keywords":4,"overallStatus":110,"whyStopped":4,"lastUpdateSubmitDate":261,"lastUpdatePostDateStruct":262,"startDateStruct":264,"completionDateStruct":266,"leadSponsor":268,"locationsCount":4},"100580527","effectiveness-of-therapeutic-exercises-on-spinopelvic-mobility-100580527","NCT06838455","Effectiveness of Therapeutic Exercises on Spinopelvic Mobility","Inclusion Criteria:\n\n1. Patients aged 18-90 scheduled for total hip arthroplasty\n2. Patients with primary hip osteoarthritis\n3. Patients with or without history of prior spinal injections\n\nExclusion Criteria:\n\n1. Patients undergoing revision total hip arthroplasty.\n2. Patients with spinal fusion.\n3. Patients who exercised prior to radiographic analysis.\n4. Patients unable to complete imaging at the designated time of day.\n5. Symptomatic contralateral hip osteoarthritis.\n6. Patients unwilling or unable to perform therapeutic exercise program as instructed. This includes patients requiring use of assistive devices or who would be deemed unsafe to perform the exercises without a 1- or 2-person assist.","90 Years",{"count":257,"type":20},53,[61],"The purpose of this study is to examine the extent to which spinopelvic exercises may affect either sagittal spinal deformity or spinopelvic mobility and identifying patients at risk for hip instability following a total hip replacement.",[26],"2025-02-17",{"date":263,"type":40},"2025-02-20",{"date":265,"type":20},"2025-02",{"date":267,"type":20},"2025-12",{"name":269,"class":85},"Colorado Joint Replacement"]